Inventor · San Diego, CA, US

Patrick Papa

25Patents
10h-index
72Co-inventors
74Inventor score

Filing activity: Oct 18, 2007 → Nov 28, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7981893B2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 73 Active
US8383634B2 Methods of treatment using heteroaryl compounds and compositions thereof Chemistry; Metallurgy 45 Active
US8492381B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Chemistry; Metallurgy 41 Active
US8110578B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway Chemistry; Metallurgy 39 Active
US8372976B2 Methods of treatment comprising the administration of heteroaryl compounds Chemistry; Metallurgy 38 Active
US7968556B2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 30 Active
US8569494B2 Methods of synthesis and purification of heteroaryl compounds Chemistry; Metallurgy 19 Active
US8299056B2 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 18 Active
US8507492B2 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway Chemistry; Metallurgy 18 Active
US9556126B2 Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 10 Active
US11149007B2 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 10 Active
US11325889B2 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 9 Active
US8907087B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 4 Active
US9156798B2 Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 4 Active
US9079900B2 Methods of synthesis and purification of heteroaryl compounds Chemistry; Metallurgy 4 Active
US9771371B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 4 Active
US9783505B2 Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 2 Active
US10167290B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 1 Active
US11873283B2 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 1 Active
US11292796B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 0 Active
US12404241B2 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith Chemistry; Metallurgy 0 Active
US9193692B2 Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors Chemistry; Metallurgy 0 Active
US10683298B2 Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors Chemistry; Metallurgy 0 Active
US11919879B2 Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases Chemistry; Metallurgy 0 Active
US12419962B2 Quinazolines, pharmaceutical compositions, and therapeutic applications Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.